Abstract: A server 40 includes a control unit 47, and the control unit 47 acquires respective planned use positions of plural users, respective destinations of the plural users, and remaining battery levels of rechargeable batteries of moving bodies which the plural users are scheduled to use, estimates, for each of the moving bodies, a required power amount of the battery based on the planned use position and the destination, determines, for each of the moving bodies, whether the remaining battery level is equal to or greater than the required power amount, and dispatches the moving body whose remaining battery level is equal to or greater than the required power amount to the planned use position.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: According to one embodiment, a semiconductor storage device includes a sense amplifier, an input/output circuit, and a control signal transmission circuit. A first clock wiring line, a second clock wiring line extending along one side surface of the first clock wiring line, and a third clock wiring line extending along the other side surface of the first clock wiring line are connected to the control signal transmission circuit. The control signal transmission circuit outputs a first clock signal to the first clock wiring line, and outputs a second clock signal having a phase being reverse-phase to the first clock signal to the second clock wiring line and the third clock wiring line. A reception-side circuit captures the data signal in response to a delay clock signal output from a clock delay circuit.

Abstract: According to one embodiment, a semiconductor integrated circuit includes a first circuit that includes a level shift transistor, a transmission line through which the signal output from the first circuit propagates, a second circuit that is connected the transmission line to receive the signal propagating through the transmission line, and a third circuit that is connected to the transmission line. The first circuit is connected to a power supply line to which a first voltage is supplied, and outputs, to the transmission line, a signal having an amplitude lower than the first voltage by a threshold voltage of the level shift transistor. The third circuit allows a current to flow from the transmission line when a voltage of the transmission line exceeds a set voltage.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.

Abstract: The present invention provides a compound having a cell degeneration inhibitory action, particularly a motor neuron degeneration inhibitory action, which is useful as an agent for the prophylaxis or treatment of motor neuron diseases (e.g., amyotrophic lateral sclerosis, progressive bulbar paralysis, progressive muscular atrophy, primary lateral sclerosis, progressive pseudobulbar paralysis, spinal muscular atrophy, Parkinson's disease, Lewy body dementia, multiple-system atrophy, Friedreich's ataxia) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: According to one embodiment, a semiconductor integrated circuit includes a first circuit that includes a level shift transistor, a transmission line through which the signal output from the first circuit propagates, a second circuit that is connected the transmission line to receive the signal propagating through the transmission line, and a third circuit that is connected to the transmission line. The first circuit is connected to a power supply line to which a first voltage is supplied, and outputs, to the transmission line, a signal having an amplitude lower than the first voltage by a threshold voltage of the level shift transistor. The third circuit allows a current to flow from the transmission line when a voltage of the transmission line exceeds a set voltage.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention aims to provide a neuron degeneration inhibitor. The present invention relates to a neuron degeneration inhibitor comprising a compound represented by the formula (I) wherein each symbol is as defined in the description, or a salt thereof.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.

Abstract: A store supporting system includes an estimation unit and an output unit. The estimation unit is configured to estimate, based on a learned model, a management index by using at least operation information as input information. The operation information is information on operation of a target store which is a specific store. The management index is an index relating to management of the target store. The learned model is generated by machine learning with data, as training data, including information on operation of a store and an index relating to management of the store. The output unit is configured to obtain, based on a result of estimation by the estimation unit, recommendation information and output the recommendation information. The recommendation information is information relating to the operation of the target store and is recommendable for the target store.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Abstract: According to one embodiment, a semiconductor memory device includes: a memory cell array; a conversion circuit; a data bus; a first buffer and a second buffer; and a third buffer. The data bus includes a first wiring part extending along a first direction. The first buffer and the second buffer are separate from each other. The first to third buffers are at different positions along the first direction.